News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ArthroCare Corporation (ARTC) Updates on Remaining Federal Issues


1/14/2013 8:29:07 AM

ArthroCare president & CEO David Fitzgerald updates on a U.S. Justice Dept. investigation into the company's spine product sales and a False Claims Act investigation that has just come to light. ArthroCare (NSDQ:ARTC) president & CEO David Fitzgerald provided highlights on the company's ongoing beef with federal investigators, telling an audience at the J.P. Morgan healthcare conference in San Francisco this week that at least 1 of the pair of remaining legacy issues may be closing soon. The Texas-based surgical devices maker has had a spate of legal troubles in recent years, including an SEC investigation that closed in February 2011 and a derivatives matter that closed in December 2011, Fitzgerald told meeting attendees. The company has yet to close the books on a U.S. Justice Dept. investigation into ArthroCare's sales & marketing pertaining to its spinal business, and is in the early stages of a False Claims Act investigation, he said.

Read at MassDevice
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES